Steven Kornfeld's most recent trade in Forte Biosciences Inc was a trade of 31,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Forte Biosciences Inc | Steven Kornfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2025 | 31,000 | 31,000 | - | - | Stock Option (right to buy) | |
| Forte Biosciences Inc | Steven Kornfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Forte Biosciences Inc | Steven Kornfeld | Director | Grant, award, or other acquisition of securities at price $ 1.01 per share. | 31 Jul 2023 | 99,009 | 99,009 | - | 1.0 | 99,999 | Common Stock |
| Forte Biosciences Inc | Steven Kornfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Forte Biosciences Inc | Steven Kornfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2022 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Forte Biosciences Inc | Steven Kornfeld | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2021 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |